XFOR Message Board Post 10920350 | X4 Pharmaceuticals Inc.
home / stock / xfor / xfor message board
(investorshangout)
Posted on: Aug/03/2022 20:35:59
Source: investorshangout
https://investorshangout.com/post/view?id=6448337
whytestocks: $ASNS News Article - Actelis Networks to Report Fiscal Second Quarter 2022 Financial Results on Thur
News, Short Squeeze, Breakout and More Instantly...
-
BOSTON, April 30, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that it will be reporting financial results for the first quarter ended March 31, 2024 and providing...
-
The FDA approved on Monday X4 Pharmaceuticals Inc’s (NASDAQ:XFOR) Xolremdi (mavorixafor) capsules for use in patients 12 years of age and ...
-
XOLREMDI targets CXCR4 pathway dysfunction, the underlying cause of WHIM syndrome Breakthrough Therapy approval follows Priority Review of 4WHIM Phase 3 clinical trial data X4 granted Rare Pediatric Disease Priority Review Voucher (PRV) concurrent with approval Conferenc...